BackCelularity- Warrants (16/07/2026) Overview

Celularity- Warrants (16/07/2026) Current Assets

Celularity- Warrants (16/07/2026)'s current assets is $12M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$12.32M
40.09% YoYΔ $-8.24M vs prior year quarter

Peer average

Loading

Celularity- Warrants (16/07/2026) Current Assets History

Loading

Celularity- Warrants (16/07/2026) vs. peers: Current Assets Comparison

Loading

Celularity- Warrants (16/07/2026) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Celularity- Warrants (16/07/2026) (CELUW) FAQ

Celularity- Warrants (16/07/2026) posts a current assets of $12M as of December 2025. That compares with $21M in the prior-year period — down 40.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Celularity- Warrants (16/07/2026)'s current assets was $21M. The latest reading is $12M — a 40.1% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Celularity- Warrants (16/07/2026)'s financial statement story. At $12M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CELUW's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Celularity- Warrants (16/07/2026)'s other metric pages and overview cover the third.

Judging Celularity- Warrants (16/07/2026) against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $12M here, then scan peer and history charts to see if the gap is persistent.